Lumos Pharma Profit Margin

The latest profit margin for LUMO is -1583.49% as of September 2024. That compares with -1816.93% in the prior-year period — up 12.8% year over year. That is below the Healthcare sector average of 19.13%. Investors often review this figure alongside Lumos Pharma's historical trend and sector peers before judging valuation or financial health.

Over the past year, LUMO's profit margin moved from -1816.93% to -1583.49% — a 12.8% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Lumos Pharma's valuation or profitability profile.

Against Healthcare companies, LUMO currently prints -1583.49% for profit margin, while the sector average sits near 19.13%. That is roughly 8377.0% below the sector mean. Large gaps often invite a closer look at Lumos Pharma's growth, margins, and balance sheet.

Profit Margin shows how effectively Lumos Pharma converts resources into returns. At -1583.49%, LUMO may look efficient or underperforming depending on peer benchmarks and trend direction. That compares with -1816.93% in the prior-year period — up 12.8% year over year. Pair the percentage with revenue growth and leverage for a fuller health check.

After noting LUMO's profit margin (-1583.49%), review year-over-year change from -1816.93%, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.